Muddy Insights
Forensic equity research, drawn from the public record.
We publish long-form investigations of listed issuers whose disclosures, in our view, do not match their economic substance. Reports cite primary sources and are produced for informational purposes only.
Reports
26 reports
NASDAQ: TROOTROOPS, Inc. (NASDAQ: TROO) — Forensic Short Update
Auditor Replaced. Lock-Up Eased. Annual Report Past Due.
TROOPS is, in our view, a Nasdaq-listed Cayman shell with a Hong Kong operating footprint engineered for asset extraction. A Hong Kong High Court has entered a final ~US$51.9M judgment, the auditor was replaced six weeks after AGM ratification, an insider lock-up was quietly amended, and the FY2025 20-F is past due.
SHORT — High conviction12-mo PTUS$0.25 – US$0.45
NSE: ADANIENTAdani Enterprises (NSE: ADANIENT)
Three years after Hindenburg, two years after OCCRP, eighteen months after the EDNY indictment — what the public record now shows.
Adani Enterprises is a politically-connected major-market Indian conglomerate whose offshore shell-network, related-party, and consolidated-leverage disclosures have, in our view, never been fully reconciled. We integrate the January 2023 short publication with the FPO withdrawal, the Supreme Court of India proceedings, the Sapre Committee, SEBI's September 2025 partial-dismissal final orders, the OCCRP disclosures, the November 2024 EDNY indictment of Gautam and Sagar Adani, and the May 2026 SEC settlement filing and reported DOJ move to drop criminal charges.
SHORT — Update- TSX: TRE
Sino-Forest Corporation (TSX: TRE)
The founding case of the modern China-short genre — fifteen years on.
Sino-Forest Corporation was, in our view, the founding case of the modern China-listed-issuer forensic-short genre — a TSX-listed Chinese forestry issuer whose standing-timber asset base and revenue model constituted a multi-billion-dollar Ponzi scheme. The OSC issued fraud findings against founder Allen Chan; the company filed CCAA in March 2012; civil and regulatory aftermath has run more than a decade.
SHORT — Closed Case - NYSE / LSE: BUR
Burford Capital (NYSE/LSE: BUR)
Six years on from Muddy Waters' mismarking thesis — what the Second Circuit's March 2026 reversal of the YPF judgment changes.
A Muddy Insights synthesis of the public record since Muddy Waters Research's August 2019 short of Burford Capital. We trace the original mark-to-model thesis, Burford's governance and listing reforms, the trajectory of the Petersen / YPF case — including the March 27, 2026 Second Circuit decision vacating the US$16B SDNY judgment that had been the largest single mark on Burford's balance sheet — and what the live debate over litigation-finance fair-value accounting looks like in the wake of that reversal.
NEUTRAL 
NASDAQ: IEPIcahn Enterprises L.P. (NASDAQ: IEP)
Three years after Hindenburg's "Pied Piper of Pumpland" — distributions, the SEC settlement, and the margin-loan unwind.
Icahn Enterprises is, in our view, a US-listed master limited partnership whose distribution was sustained at a level the underlying portfolio could not support, while founder Carl Icahn pledged a material portion of his unit holding as collateral for personal margin loans. The unit distribution was cut twice (US$2.00 → US$1.00 → US$0.50 quarterly), the personal margin loans were untied from the IEP unit price (July 2023), and the SEC settled non-disclosure charges in August 2024.
SHORT — Update
XETRA: WDIWirecard AG (XETRA: WDI) — Closed-Case Retrospective
Six years after the €1.9B missing cash — what a streamlined trial, a €140M civil award, and the Marsalek-as-FSB-asset disclosures now confirm.
Wirecard was, in our view, a XETRA-listed German payments issuer whose disclosed Asian processing operations and €1.9B in trust-account balances did not exist. Following the *Financial Times* investigations, the KPMG special audit, and the June 2020 insolvency, subsequent dispositions have included the September 2024 €140M civil-liability judgment against Markus Braun and others, the February 2025 streamlining of the Munich criminal trial, and the 2025 disclosures confirming Jan Marsalek's operational role as a Russian FSB asset.
SHORT — Closed Case
NASDAQ: NKLANikola Corporation (NASDAQ: NKLA)
The Hindenburg short, the Milton conviction, the Trump pardon, and the company's own Chapter 11.
Nikola Corporation was, in our view, a SPAC-listed hydrogen-truck issuer whose pre-revenue claims about working trucks, in-house technology, and order pipeline did not reflect operational reality. Founder Trevor Milton resigned (September 2020), was convicted of securities and wire fraud (October 2022) and sentenced (December 2023); the company filed Chapter 11 in February 2025; Milton received a presidential pardon in March 2025; and the Chapter 11 plan became effective December 2025.
SHORT — Closed Case- NASDAQ: MAGH
Magnitude International Ltd. (NASDAQ: MAGH) — Forensic Short
Penny-Priced Pre-IPO Equity, Eight-Month Cashout, Resale Shelf Engineered for Insider Exit.
MAGH is, in our view, a Cayman-domiciled Singapore electrical subcontractor whose August 2025 NASDAQ IPO functioned as an insider exit rather than a capital raise. The Chairman issued himself ~76% of the company for US$0.02/share eight months before pricing the IPO at US$4.00, registered 8.8M insider shares (25% of the company) for immediate resale with no enforced lock-up, and quietly transferred a 3.4% stake to an apparent nominee tied to a related-party customer.
SHORT — High conviction12-mo PTBelow US$1.00 
NYSE: VRXValeant Pharmaceuticals (NYSE: VRX, now Bausch Health: BHC)
Citron's "Pharmaceutical Enron" call, the Philidor disclosure, and the ten-year recovery that never came.
Valeant Pharmaceuticals was, in our view, a serial-acquirer specialty-pharmaceutical issuer whose growth rested on a specialty-pharmacy distribution channel (Philidor) that masked underlying drug-pricing pressure and integration risk. The Philidor disclosure crystallized the short thesis (October 2015), CEO J. Michael Pearson resigned, the company rebranded as Bausch Health, and a long, partial deleveraging has followed.
SHORT — Closed Case- NASDAQ: TIO
Tingo Group (NASDAQ: TIO)
Hindenburg's June 2023 short, SEC fraud charges, the $250M civil judgment, and the founder still at large.
Tingo Group was, in our view, a Nasdaq-listed Nigerian agri-fintech issuer whose reported revenue, customer base, and fintech platform did not exist at the scale claimed. SEC fraud charges (December 2023) and the criminal indictment of founder Dozy Mmobuosi (January 2024) followed; the August 2024 SDNY final judgment required disgorgement of approximately US$157M plus US$20M prejudgment interest, with a parallel August 2025 final judgment against the Nigerian auditor Olayinka Oyebola. Mmobuosi remains at large.
SHORT — Closed Case 
NASDAQ: EBIXEbix, Inc. (NASDAQ: EBIX)
Hindenburg's June 2021 short, the December 2023 Chapter 11, the $400M Zinnia sale, and the August 2024 emergence under Eraaya LifeSpaces sponsorship.
Ebix is, in our view, a US-listed insurance-and-fintech roll-up whose India-fintech and EbixCash IPO-pipeline disclosures concealed a deteriorating consolidated capital structure. The company filed Chapter 11 in the Northern District of Texas (December 2023), sold its North American Life & Annuity assets to Zinnia for US$400M (April 2024), and emerged from Chapter 11 in August 2024 with Eraaya LifeSpaces as plan sponsor.
SHORT — Update
ATHEX: FFGRPFolli Follie (ATHEX: FFGRP)
QCM's May 2018 short, the largest stock-market fraud in modern Greek history, and the June 2024 prison sentences.
Folli Follie was, in our view, a Greek listed accessories and retail conglomerate whose reported Asian retail revenue and store-network footprint did not reflect on-the-ground operational reality. The Greek Capital Markets Commission confirmed multi-billion-euro overstatement, the listed entity wound down through rehabilitation proceedings (Nov 2023 business transfer), and the June 2024 Athens court sentenced founder Dimitris Koutsolioutsos to 17 years, with 10- to 11-year sentences for his wife and son.
SHORT — Closed Case
JSE: SNHSteinhoff International (JSE: SNH)
Viceroy's December 2017 short, €7B+ of confirmed accounting irregularities, and the July 2023 vote to dissolve.
Steinhoff International was, in our view, a JSE-listed multinational retail conglomerate whose consolidated accounts concealed multi-year accounting irregularities at the €7B+ scale. CEO Markus Jooste resigned (December 2017), PwC's forensic investigation confirmed the irregularities, the Dutch WHOA restructuring followed, the July 2023 shareholder vote dissolved the listing, the October 2023 conversion to contingent-value-right structure closed the equity, and Jooste died in March 2024.
SHORT — Closed Case
NASDAQ: RIDELordstown Motors (NASDAQ: RIDE, now Nu Ride: NRDE)
From SPAC pre-orders to Chapter 11 to a litigation-vehicle reorganization.
Lordstown Motors was, in our view, a SPAC-listed electric-pickup issuer whose disclosed pre-order book did not reflect binding commercial orders. Executive departures, a June 2023 Chapter 11 filing, a February 2024 SEC settlement, and a March 2024 emergence as Nu Ride Inc. — a litigation-vehicle reorganization centered on the company's lawsuit against Foxconn — followed.
SHORT — Closed Case- NYSE → GOTU: GSX
GSX Techedu (NYSE: GSX, now Gaotu: GOTU)
Muddy Waters' May 2020 short, the July 2021 "double reduction" policy that vindicated the broader sector thesis, and the 2022 HFCAA delisting.
GSX Techedu was, in our view, an NYSE-listed China after-school-tutoring issuer whose disclosed student enrollment was substantially fabricated. The case closed via a sectoral policy intervention — China's July 2021 "double reduction" policy — that effectively ended for-profit after-school tutoring in China rather than via micro-level enforcement. The company renamed to Gaotu Techedu and was delisted from NYSE under HFCAA in 2022.
SHORT — Closed Case 
NYSE: EROSEros International / Eros STX Global (NYSE: EROS, formerly)
Kerrisdale's November 2015 short, the 2020 merger with STX Entertainment, and the 2022 separation that effectively ended the listed parent.
Eros International was, in our view, an NYSE-listed Bollywood film distributor whose reported revenue and receivables disclosures did not reflect arms-length cash collection from the underlying content business. The closure ran through multiple corporate-action stages: the July 2020 merger with STX Entertainment to form Eros STX Global, subsidiary-level bankruptcies in 2022, and the April 2022 separation of STX to The Najafi Companies that effectively ended the original Eros listed structure.
SHORT — Closed Case- LSE (AIM): QPP
Quindell PLC (LSE AIM: QPP, now Watchstone)
Gotham City Research's April 2014 short, the £637M Slater & Gordon sale, the £11M settlement that followed, and the SFO investigation that ended without charge.
Quindell PLC was, in our view, an LSE AIM-listed UK insurance-services issuer whose cash-flow quality and acquisition-accounting disclosures did not reflect underlying operating cash conversion. The May 2015 £637M sale of the legal-services arm to Slater & Gordon, the 2019 £11M settlement of S&G's £637M deceit claim, the 2018 KPMG £4.5M FRC fine, and the SFO's 2021 decision to end its investigation without charge followed; the listed entity is now Watchstone.
SHORT — Closed Case - NASDAQ: SONG
Akazoo S.A. (NASDAQ: SONG)
QCM's April 2020 short, SEC fraud charges, and the fastest US-regulator resolution of a SPAC-era fraud.
Akazoo S.A. was, in our view, a Nasdaq-listed music-streaming issuer (Modern Media Acquisition Corp SPAC merger) whose disclosed subscriber numbers were fabricated. SEC fraud charges (September 2020) and the company's delisting followed; investor funds were partially recovered through Nasdaq's SPAC merger consideration.
SHORT — Closed Case - NASDAQ: INSY
Insys Therapeutics (NASDAQ: INSY)
Citron's August 2016 short, the Subsys opioid-marketing prosecution, the June 2019 bankruptcy, and the first US pharmaceutical-executive RICO conviction for opioid marketing.
Insys Therapeutics was, in our view, a Nasdaq-listed specialty-pharmaceutical issuer whose Subsys (fentanyl sublingual spray) revenue model rested on marketing practices that constituted commercial bribery of prescribing physicians. Founder John Kapoor and four senior executives were convicted of racketeering in May 2019 — the first US pharmaceutical-executive RICO conviction in connection with opioid marketing — and the company filed Chapter 11 in June 2019.
SHORT — Closed Case - Borsa Italiana (AIM Italia): ON
Bio-on S.p.A. (Borsa Italiana AIM: ON) — Forensic Short Closed Case
Auditor-quality bioplastics revenue, a same-quarter founder arrest, and the fastest closure of any modern European forensic-short case.
Bio-on was, in our view, an Italian listed bioplastics issuer whose reported PHA-licensing revenue did not reflect arms-length commercial sales. Trading was suspended on AIM Italia; founder Marco Astorri was arrested in October 2019; the Bolognese courts placed the company into compulsory liquidation in December 2019 — less than five months after the original short publication.
SHORT — Closed Case 
SGX: N21Noble Group (SGX: N21)
Iceberg Research's February 2015 short, multi-year mark-to-model contestation, and the 2018 break-up of one of Asia's largest commodity traders.
Noble Group was, in our view, an SGX-listed commodity-trading conglomerate whose mark-to-model accounting on the commodity-trading book did not reflect realizable cash recoveries. The multi-year share-price collapse, SGX and Monetary Authority of Singapore investigations, and the 2018 restructuring under which creditors took 70% of "New Noble" effectively broke up the historical listed entity.
SHORT — Closed Case
NYSE: NQNQ Mobile (NYSE: NQ)
Muddy Waters' October 2013 short, four years of contested public posture, and the eventual NYSE delisting in 2017.
NQ Mobile was, in our view, an NYSE-listed Chinese mobile-security issuer whose disclosed China security revenue was approximately 72% fictitious for 2012. The multi-year public dispute, auditor changes, the eventual NYSE delisting in 2017, and the sale of the core security business followed.
SHORT — Closed Case- NASDAQ (delisted 2013); re-listed Shenzhen 002027: FMCN
Focus Media (NASDAQ: FMCN, formerly)
Muddy Waters' November 2011 short, the 2013 take-private at a premium, and the 2015 China A-share relisting at a multiple of the take-private price.
Focus Media Holding is the most-discussed counter-example in the China-listed-issuer forensic-short genre. The November 2011 short publication alleged sham acquisitions and inflated network screen counts; the issuer subsequently went private at approximately US$3.7B in 2013 via a Carlyle-led consortium and relisted in Shenzhen in 2015 at a multiple of the take-private valuation.
SHORT — Counter-Case - BME (Mercado Alternativo Bursátil): GOW
Let's Gowex (BME MAB: GOW)
Gotham City Research's July 2014 short, the CEO confession within days, and the fastest forensic-short to bankruptcy in the modern catalogue.
Let's Gowex was, in our view, a Spanish municipal-Wi-Fi issuer whose reported revenue and customer base were largely fabricated. Founder and CEO Jenaro García publicly confessed within five days of the original short publication, the company filed for bankruptcy, and Spanish criminal proceedings against García followed.
SHORT — Closed Case - NASDAQ: CCME
China MediaExpress Holdings (NASDAQ: CCME)
Muddy Waters' February 2011 short, auditor Deloitte's resignation, and the SEC fraud charges that followed.
China MediaExpress Holdings was, in our view, a Cayman / China bus-advertising issuer whose disclosed revenue and operating-fleet scale did not reflect underlying operational substance. Auditor Deloitte resigned within five weeks of the original short publication, Nasdaq delisted the company, and the SEC pursued civil fraud charges resulting in permanent officer-and-director bars.
SHORT — Closed Case - NYSE: LFT
Longtop Financial Technologies (NYSE: LFT)
Citron's April 2011 short, Deloitte's May 2011 resignation letter, and the SEC's signature fraud case of the 2011 China-short wave.
Longtop Financial Technologies was, in our view, an NYSE-listed Chinese financial-technology issuer whose disclosed bank-confirmation records were fabricated. Deloitte issued an unusually-direct May 2011 resignation letter alleging fabricated bank confirmations; the NYSE delisted the company; SEC fraud charges followed, including a parallel SEC action against the audit personnel.
SHORT — Closed Case